Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | January 20, 2023 08:55am

 

Gainers

• Genius Group Limited (NYSE:GNS) rose 52.2% to $3.18 in pre-market trading. Genius Group shares jumped 290% on Thursday after the company approved a plan to create an 'Illegal Trading Task Force.'
• Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) rose 32.3% to $0.94 in pre-market trading after gaining 8% on Thursday. Lytus Technologies, last month, filed for offering of up to 20.9 million common shares by the selling shareholders.
• Helbiz, Inc. (NASDAQ:HLBZ) shares rose 30.3% to $0.1604 in pre-market trading. Helbiz recently announced discontinuation of operations in non-profitable markets.
• WiSA Technologies, Inc. (NASDAQ:WISA) rose 29% to $0.1591 in pre-market trading after gaining over 29% on Thursday.
• BiomX Inc. (NYSE:PHGE) shares rose 18.3% to $0.2999 in pre-market trading after dropping 6% on Thursday. BiomX, during November, posted a Q3 loss of $0.23 per share.
• Cazoo Group Ltd (NASDAQ:CZOO) rose 14.2% to $0.24 in pre-market trading after dropping 15% on Thursday. Cazoo sees Q4 UK retail unit sales of 17,750 in the fourth quarter.
• Ontrak, Inc. (NASDAQ:OTRK) shares rose 11.6% to $1.35 in pre-market trading after gaining 8% on Thursday. Ontrak recently announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
• Astra Space Inc (NASDAQ:ASTR) rose 9.9% to $0.6155 in pre-market trading after declining around 9% on Thursday. Astra Space, during November, posted a Q3 loss of $0.75 per share.
• Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) rose 7.5% to $3.85 in pre-market trading. Salarius Pharmaceuticals will present SP-3164 targeted protein degrader preclinical data at the inaugural Molecular Glue Drug Development Summit.
• Netflix, Inc. (NASDAQ:NFLX) rose 5.8% to $334.15 in pre-market trading. Netflix reported downbeat earnings for the fourth quarter, while sales topped expectations. Netflix added 7.7 million paid subscribers during the quarter, which was well ahead of company expectations of 4.5 million. The company’s co-founder Reed Hastings stepped down as the chief executive and will be serving as Executive Chairman.

Losers

• Tempo Automation Holdings Inc (NASDAQ:TMPO) fell 17.6% to $1.50 in pre-market trading. Northland Capital Markets recently initiated coverage on the stock with an Outperform rating and a $3 price target.
• Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares fell 14.2% to $0.24 in pre-market trading after gaining 23% on Thursday.
• Calyxt, Inc. (NASDAQ:CLXT) fell 11.7% to $0.2121 in pre-market after declining around 8% on Thursday. Calyxt and Cibus recently announced a definitive merger agreement.
• NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) fell 11.3% to $1.97 in pre-market trading. The company filed for mixed-securities shelf offering of up to $100 million. NeuroSense Therapeutics shares jumped 78% on Thursday after the company reported final results from its Alzheimer's biomarker study.
• Celyad Oncology SA (NASDAQ:CYAD) fell 10.4% to $1.97 in pre-market trading after dropping 7% on Thursday. Celyad Oncology, last month, reported it has decided to discontinue the development of its remaining clinical program CYAD-211.
• Synlogic, Inc. (NASDAQ:SYBX) fell 9.7% to $0.9034 in pre-market trading. Synlogic was granted Rare Pediatric Disease Designation from the FDA for SYNB1934 for phenylketonuria.
• Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares fell 9.5% to $1.10 in pre-market trading after the company filed for common stock offering. Sonnet BioTherapeutics, on Thursday, announced that pharmacokinetic (PK) profile simulation of SON-1010 dosing had been completed in its Phase 1 trial in healthy volunteers.
• Bed Bath & Beyond Inc (NASDAQ:BBBY) fell 8.7% to $3.46 in pre-market trading. Bed Bath & Beyond received a notice from NASDAQ regarding delayed quarterly report.
• Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares dropped 8.2% to $0.89 in pre-market trading. Sunshine Biopharma, on Thursday, reported a share repurchase program to acquire up to $2 million of the company's common stock.
• Amesite Inc. (NASDAQ:AMST) fell 8.2% to $0.30 in pre-market trading after surging 22% on Thursday.

 

Posted In: AMST ASTR BBBY CLXT CNXA CYAD CZOO GNS HLBZ LYT NFLX NRSN OTRK PHGE SBFM SLRX SONN SYBX TMPO WISA